Guillaume CFO

Vésale Bioscience calls on beLean.net to prepare and accelerate its IPO

Vésale Bioscience has hired Guillaume de Viron, Partner at beLean.net, as Chief Financial Officer in order to accelerate its IPO. As CFO, Guillaume de Viron will contribute to Vésale Bioscience, which is currently preparing its fundraising (10+ million €) with the aim of accelerating the production and marketing of phages. Phage therapy is the use of phages,[…]

BIDAYS

Be part of the Brain Innovation Days physical event!

The European Brain Council and beLean.net are excited to announce that after one year of digital sessions, the Brain Innovation Days will take place in person on 12-13 October 2021 in Brussels, Belgium and we invite you to Save the Date! Add to Calendar Under the overarching theme, United for Brain Innovation, the Brain Innovation Days will bring together key opinion leaders and stakeholders from the[…]

pocare-platform-img-3 (1)

Initial success for Orgenesis’ POCare Platform

Pharmaceutical companies used to be eager buyers of technology. But in recent years, biotech platforms have benefited from easier access to capital as independent entities, eliminating the need to sell. At the same time, biopharma companies large and small are realizing that building a platform is better than focusing on a single product or production[…]

Workshop PIPRA & icompanion copie

Looking back to the workshops with the BIDays Pitch Competition winners

The Brain Innovation Days hosted its first-ever Pitch Competition in January 2021. Out of 90 applications, 2 European start-ups particularly impressed the jury and the public: PIPRA, which is developing a cutting-edge AI-based pre-operative test to prevent post-operative delirium (Jury Award for Best Pitch); and icompanion, the digital companion for people with neurological conditions and their physicians (Public Award for Best Pitch).[…]

Imcyse

Imcyse signs licensing agreement with Pfizer

Imcyse raises €21M and opens its capital to its new American partner, Pfizer. Very good news for the Liège-based biotech company Imcyse. Indeed, the biotech has developed an active immunotherapy technology that allows to tackle autoimmune diseases such as multiple sclerosis, type 1 diabetes or rheumatoid arthritis. A licensing agreement has just been signed with[…]

Screenshot 2021-03-31 at 15.23.21

Brain Innovation Days Session #3 – Register Now!

Registration is now open for the upcoming Brain Innovation Days Digital Session, Fast-tracking brain innovation in times of COVID-19, which we are co-organising with the European Brain Council on 27 April at 12:30-14:00. REGISTER NOW The last 14 months have been testing for global health. COVID-19 exposed weaknesses in public health systems’ preparedness to face pandemics and we continue to face[…]

Discussion with PIPRA

Discover how PIPRA aims to prevent Post-Operative Delirium

Listen to the latest edition of Brain Talks, a podcast series under the Brain Innovation Days umbrella Under the overarching theme, “Disrupt and rewire: How brain innovation is changing Europe”, the Brain Innovation Days aim to bring together key opinion leaders and stakeholders from the ever-growing brain innovation ecosystem to create synergies and showcase the importance of[…]

TOP 20 Belgian Biotech Companies 2021

TOP 20 Belgian Biotech Companies 2021

Belgium and its companies at the forefront of the biotechnology industry in Europe Belgium is spearheading the European biotech industry. Meet some of the most successful cases of Belgian biotechnology companies. Belgium is one of the countries that provide the most to the biotech industry in Europe, as it has a total of more than[…]

BIDays#2 - Thank you!

Relive the key moments of the Brain Innovation Days Pitch Competition

We were excited to welcome you to the second digital session of the Brain Innovation Days last week – thank you for joining us! We would like to thank our excellent line-up of guest speakers representing the European Innovation Council, Roche, JLABS – Johnson & Jonhson Innovation, Brain+, Helpilepsy and EIT Health for their valuable insight. Furthermore, thank you to our 9 Pitch Competition[…]